The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
April 25th 2025
An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
Vendors refine offerings to boost efficiency
February 11th 2006In the wake of the U.S. holiday of Thanksgiving every year, a city rises within the confines of Chicago's McCormick Place. It is a kind of radiological Epcot Center, a futuristic vision designed to dazzle; constructed of software, heavy iron, and handhelds; and swathed in platitudes.
Imaging offers insight into blood-brain permeability
February 11th 2006Neuroradiologists understand that high-grade tumors interrupt the blood-brain barrier, which presents as contrast enhancement on CT and MRI. Renewed interest in the phenomenon of permeability, however, has researchers looking beyond simple contrast enhancement and toward molecular mechanisms involved in permeability that may help them treat brain tumors more effectively.
Convert turf battles into productive joint ventures
February 11th 2006Since the introduction of cardiac catheterization in the 1940s, development and implementation of cardiovascular imaging techniques have been a collaborative effort among several specialties, particularly radiology and cardiology. Many pioneers in CV imaging have held joint appointments.
Poster prizewinners include controversial imaging agent
February 11th 2006On the same day that New York researchers received the top honor at the RSNA meeting for their poster detailing the benefits of an infection imaging agent, the drug's maker issued a warning about two deaths and additional serious adverse events attributed to the drug's use. The admonition was released by Tyco Mallinckrodt Healthcare, which markets NeutroSpec (technetium-99m fanolesomab), a monoclonal antibody-labeled radiopharmaceutical agent approved in the U.S. for the diagnosis of equivocal appendicitis.
Report from SCMR: MR travels a long way to test blood disease treatment
February 6th 2006In a laborious clinical trial that involved hauling a mobile MR scanner over land and sea to the Mediterranean island of Sardinia, British researchers used T2* imaging to confirm the value of a new drug treatment for Β-thalassemia, a genetic blood disorder.
Brain MRI stands up to polygraph test
January 30th 2006Traditional polygraph tests to determine whether someone is lying may take a back seat to fMRI, according to a study in the February issue of Radiology. Researchers from Temple University Hospital used fMRI to show how specific areas of the brain light up when a person tells a lie.
Report from SCMR: DE-CMR stratifies risk for dilated cardiomyopathy patients
January 23rd 2006Delayed-enhancement cardiac MR imaging has been widely adopted as a powerful test for predicting the success of revascularization for heart attack patients. DE-MRI can significantly improve risk stratification of dilated cardiomyopathy patients as well, according to results of a prospective trial reported at the ninth annual meeting of the Society for Cardiovascular Magnetic Resonance held in Miami Jan. 20 to 22.
HITLab and the future of imaging
January 23rd 2006In 1997, while visiting the University of Washington, I dropped in on the Human Interface Technology Laboratory, known to the locals simply as HITLab. What drew me there was research into a surgical simulator. But what captured my imagination was a project exploring the concept of “virtual space” and an offshoot called “telesavance.”
RFA vies with surgery for treating liver tumors
January 17th 2006Radiofrequency ablation is as effective as resection for treatment of hepatocellular carcinoma, according to a study presented at the joint RSNA/SIR Foundation Interventional Oncology Symposium. The key factor is RFA's ability to easily repeat treatment on recurring tumors in a less destructive fashion than surgery.
Pancreatic imaging gets the flavor of the tropics
January 17th 2006Could patients with possible biliary and/or pancreatic disease soon be offered a pina colada before imaging? Not quite, but a team of Belgian radiologists has started serving pineapple juice labeled with gadolinium to boost the quality of its MR cholangiopancreatography scans.
Vendors refine offerings to suit efficiency mantra
January 17th 2006In the wake of Thanksgiving every year, a city rises within the confines of McCormick Place. It is a kind of radiological Epcot Center, a futuristic vision designed to dazzle; constructed of software, heavy iron, and handhelds; and swathed in platitudes.
Advanced MR imaging in epilepsy assists presurgical evaluation
January 17th 2006Two different advanced MRI techniques can help clinicians choose epilepsy patients who will favorably respond to surgical intervention, according to a pair of studies published in the October 2005 issue of Neurology.
Diffusion tensor imaging delivers crucial information
January 17th 2006Tensor imaging and tractography are diffusion-based MR techniques for advanced functional imaging of brain white matter.1 Imaging brain anisotropy can yield useful information about white matter integrity and demonstrate pathology occult to conventional imaging techniques. Anisotropy imaging can also provide information about ordered white matter (WM) tracts such as directional orientation and connectivity, which can be critical in surgical planning and useful in the understanding of certain developmental and acquired disease states.
Poster prizewinners include controversial imaging agent
January 17th 2006On the same day that New York researchers received the top honor at the RSNA meeting for their poster detailing the benefits of an infection imaging agent, the drug's maker issued a warning about two deaths and additional serious adverse events attributed to its use. The admonition was released by Tyco Mallinckrodt Healthcare, which markets NeutroSpec (technetium-99m fanolesomab), a monoclonal antibody-labeled radiopharmaceutical agent approved in the U.S. for the diagnosis of equivocal appendicitis.
External fixation devices and MRI safety
January 17th 2006Most orthopedic implants and materials do not pose problems for patients undergoing MRI procedures. MRI may be hazardous for external fixation systems, however, because of the length of the implant or the formation of a conductive loop.
MRI catches beating fetal heart
January 17th 2006Researchers from The Children's Hospital of Philadelphia have performed real-time functional cardiac MRI in two fetuses. It is the first time this technique has been reported, and it may represent an advance over the current gold standard of fetal echocardiography.
Diffusion MR technique shows promise for pediatric lung assessment
December 14th 2005Hyperpolarized helium-3 diffusion MR can detect alveolar changes due to lung disease in children and provide quantitative data on airflow to the peripheral lobes, according to research presented at the RSNA meeting.
Major pelvic joint surgery isn’t always hip
December 13th 2005Early diagnosis of femoro-acetabular impingement syndrome could prevent degenerative arthritis of the hip. It may keep young patients from potentially expensive, and possibly disastrous, invasive treatment interventions, according to research presented at the RSNA meeting.